<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04394923</url>
  </required_header>
  <id_info>
    <org_study_id>AWESOME-AF</org_study_id>
    <nct_id>NCT04394923</nct_id>
  </id_info>
  <brief_title>Relationship Between the Posterior Atrial Wall and the Esophagus: Esophageal Position and Temperature MEasurement During Atrial Fibrillation Ablation.</brief_title>
  <acronym>AWESOME-AF</acronym>
  <official_title>Impact of Pulmonary Vein Isolation (PVI) Line Modification Based on the Multidetector Computed Tomography (MDCT)-Derived Fingerprinted Esophageal Distance to the Posterior Wall of the Left Atrium, on the Esophageal Temperature Raise Measured With an Intraluminal Esophageal Temperature Monitoring Lead. A Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Medico Teknon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Medico Teknon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multimodal strategy integrating esophageal visualization with the multidetector computed
      tomography (MDCT) and simultaneous temperature monitoring has never been put into practice.
      We have developed an isodistance map (esophageal print) to depict the atrio-esophageal
      relationship and to analyze the esophageal position peri procedurally. The present randomized
      study intends to analyze the usefulness of the esophageal print in predicting local thermal
      heating of the esophagus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective: to validate the usefulness of the esophageal print in avoiding temperature
      rises caused by radiofrequency (RF) application at the left atrial (LA) posterior wall during
      atrial fibrillation ablation

      Secondary objectives:

        1. to establish if there is a linear relationship between intraesophageal temperature rise
           and atrio-esophageal distance as calculated by the MDCT-derived esophageal print.

        2. to analyze the need for ablation line modification.

        3. to analyze the need for energy (power settings, ablation index, ablation time, etc.)
           modification.

        4. to develop a new multimodal approach to esophageal monitoring during AF/AT ablation.

      Interventions

        1. Pre-procedural scan and Esophageal Isodistance Print

           The methods for the acquisition of the cardiac MDCT and the image processing have been
           described in Part 1. During the segmentation process, the epicardial layer of the
           posterior atrial wall and the esophageal wall have been defined. The distance between
           these two structures is computed at each epicardial point, allowing to create an
           esophageal print on top of the epicardial layer. The isodistance color map uses a color
           scale to depict a range of distance; red being the closest (&lt; 1 mm) and purple being the
           most distant (&gt; 4 mm). Yellow, green and blue will be considered the intermediate
           values.

        2. Luminal esophageal temperature (LET) monitoring

           A multi-thermocouple temperature probe (SensiTherm, St. Jude Medical, Inc., St. Paul,
           MN, USA) will be advanced via transnasal or transoral access into the esophagus once the
           patient is under general anesthesia. When the esophageal print is close to the ablation
           line, the temperature probe position will be adjusted under fluoroscopic guidance before
           application at each pair of pulmonary veins to ensure that it overlaps the ablation
           line. All esophageal temperature rises above 39 °C will be documented and RF application
           will be stopped.

        3. Pulmonary vein ablation lines regarding Esophageal Isodistance Print

      Before randomization, an investigator blinded to the esophageal position will draw the PVI
      ablation line around both pairs of veins based on the type of AF (closer to the ostium for
      paroxysmal AF and wider for persistent AF).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2020</start_date>
  <completion_date type="Anticipated">May 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single center, prospective, randomized pilot study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants presenting a temperature rise as measured with a luminal esophageal temperature probe during radiofrequency delivery. The temperature is measured in Celsius degrees.</measure>
    <time_frame>1 day</time_frame>
    <description>Number of intraesophageal temperature rises above 39°C or absolute temperature raises of 2°C degrees. The chosen probe is St Jude</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients needing ablation power or ablation time modification owing to esophageal presence in the immediate posterior wall .</measure>
    <time_frame>1 day</time_frame>
    <description>Modification of the ablation parameters.Power is measured in Watts during radiofrequency application. Ablation time is measured in seconds of radiofrequency application. Both measures are provided by the electroanatomical navigation system.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Atrial Arrhythmia</condition>
  <arm_group>
    <arm_group_label>Intervention group or &quot;PRINT&quot; group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The ablation line previously drawn will be modified regarding the esophageal print position in order to avoid RF application within the red layer of the esophageal print, which is the zone where the atrioesophageal distance is shorter. The maximal distance and the area between the original line and the modified line will be noted. In cases when ablation through the red layer is unavoidable, the delivered energy can be lowered to an ablation index (AI) of 300 regardless of the local wall thickness. If the temperature rises above 39℃, ablation will be immediately stopped, and energy will be reduced.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The ablation line will not be modified from the original one drawn before randomization and RF applications will follow the regular path. If the temperature rises above 39℃, ablation will be immediately stopped, and energy will be reduced.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modification of the pulmonary vein ablation line</intervention_name>
    <description>The ablation line previously drawn will be modified regarding the esophageal print position in order to avoid RF application within the red layer of the esophageal print.</description>
    <arm_group_label>Intervention group or &quot;PRINT&quot; group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Regular PVI ablation</intervention_name>
    <description>Blinded to the esophageal position based on the type of AF, closer to the ostium for paroxysmal AF and wider for persistent AF</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years.

          -  Indication for any atrial fibrillation or left atrial flutter ablation procedure.

          -  Documented episodes of atrial arrhythmia (AF/AT/AFL)

          -  Signed informed consent.

        Exclusion Criteria:

          -  Age &lt; 18 years.

          -  Pregnancy.

          -  Impossibility to perform CT Scan.

          -  Impossibility to perform transesophageal echocardiography or to insert esophageal
             temperature monitoring probe.

          -  Concomitant investigation treatments.

          -  Medical, geographical and social factors that make study participation impractical

          -  Inability to give written informed consent.

          -  Patient's refusal to participate in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antonio Berruezo, MD, PhD</last_name>
    <phone>(+34) 932 290 62 51</phone>
    <email>antonio.berruezo@quironsalud.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beatriz Jauregui, MD</last_name>
    <phone>(+34) 932 290 62 51</phone>
    <email>beatriz.jauregui@quironsalud.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Teknon Medical Center</name>
      <address>
        <city>Barcelona</city>
        <zip>08017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Antonio Berruezo, MD, PhD</last_name>
      <phone>(+34) 932 290 62 51</phone>
      <email>antonio.berruezo@quironsalud.es</email>
    </contact>
    <contact_backup>
      <last_name>Beatriz Jauregui, MD</last_name>
      <phone>(+34) 932 290 62 51</phone>
      <email>beatriz.jauregui@quironsalud.es</email>
    </contact_backup>
    <investigator>
      <last_name>Cheryl Teres, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Diego Penela, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Soto, MSc, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.</citation>
    <PMID>27567408</PMID>
  </reference>
  <reference>
    <citation>Suenari K, Nakano Y, Hirai Y, Ogi H, Oda N, Makita Y, Ueda S, Kajihara K, Tokuyama T, Motoda C, Fujiwara M, Chayama K, Kihara Y. Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart Vessels. 2013 May;28(3):360-8. doi: 10.1007/s00380-012-0253-6. Epub 2012 Apr 22.</citation>
    <PMID>22526381</PMID>
  </reference>
  <reference>
    <citation>Sánchez-Quintana D, Cabrera JA, Climent V, Farré J, Mendonça MC, Ho SY. Anatomic relations between the esophagus and left atrium and relevance for ablation of atrial fibrillation. Circulation. 2005 Sep 6;112(10):1400-5. Epub 2005 Aug 29.</citation>
    <PMID>16129790</PMID>
  </reference>
  <reference>
    <citation>Lakkireddy D, Reddy YM, Atkins D, Rajasingh J, Kanmanthareddy A, Olyaee M, Dusing R, Pimentel R, Bommana S, Dawn B. Effect of atrial fibrillation ablation on gastric motility: the atrial fibrillation gut study. Circ Arrhythm Electrophysiol. 2015 Jun;8(3):531-6. doi: 10.1161/CIRCEP.114.002508. Epub 2015 Mar 14.</citation>
    <PMID>25772541</PMID>
  </reference>
  <reference>
    <citation>Lemola K, Sneider M, Desjardins B, Case I, Han J, Good E, Tamirisa K, Tsemo A, Chugh A, Bogun F, Pelosi F Jr, Kazerooni E, Morady F, Oral H. Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation. Circulation. 2004 Dec 14;110(24):3655-60. Epub 2004 Nov 29.</citation>
    <PMID>15569839</PMID>
  </reference>
  <reference>
    <citation>Tsao HM, Wu MH, Higa S, Lee KT, Tai CT, Hsu NW, Chang CY, Chen SA. Anatomic relationship of the esophagus and left atrium: implication for catheter ablation of atrial fibrillation. Chest. 2005 Oct;128(4):2581-7.</citation>
    <PMID>16236927</PMID>
  </reference>
  <reference>
    <citation>Kennedy R, Good E, Oral H, Huether E, Bogun F, Pelosi F, Morady F, Chugh A. Temporal stability of the location of the esophagus in patients undergoing a repeat left atrial ablation procedure for atrial fibrillation or flutter. J Cardiovasc Electrophysiol. 2008 Apr;19(4):351-5. Epub 2007 Dec 12.</citation>
    <PMID>18081769</PMID>
  </reference>
  <reference>
    <citation>Starek Z, Lehar F, Jez J, Scurek M, Wolf J, Kulik T, Zbankova A. Esophageal positions relative to the left atrium; data from 293 patients before catheter ablation of atrial fibrillation. Indian Heart J. 2018 Jan - Feb;70(1):37-44. doi: 10.1016/j.ihj.2017.06.013. Epub 2017 Jun 29.</citation>
    <PMID>29455785</PMID>
  </reference>
  <reference>
    <citation>Barbhaiya CR, Kumar S, Guo Y, Zhong J, John RM, Tedrow UB, Koplan BA, Epstein LM, Stevenson WG, Michaud GF. Global Survey of Esophageal Injury in Atrial Fibrillation Ablation: Characteristics and Outcomes of Esophageal Perforation and Fistula. JACC Clin Electrophysiol. 2016 Apr;2(2):143-150. doi: 10.1016/j.jacep.2015.10.013. Epub 2015 Dec 23.</citation>
    <PMID>29766863</PMID>
  </reference>
  <reference>
    <citation>Halbfass P, Pavlov B, Müller P, Nentwich K, Sonne K, Barth S, Hamm K, Fochler F, Mügge A, Lüsebrink U, Kuhn R, Deneke T. Progression From Esophageal Thermal Asymptomatic Lesion to Perforation Complicating Atrial Fibrillation Ablation: A Single-Center Registry. Circ Arrhythm Electrophysiol. 2017 Aug;10(8). pii: e005233. doi: 10.1161/CIRCEP.117.005233.</citation>
    <PMID>28798021</PMID>
  </reference>
  <reference>
    <citation>Kapur S, Barbhaiya C, Deneke T, Michaud GF. Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation. Circulation. 2017 Sep 26;136(13):1247-1255. doi: 10.1161/CIRCULATIONAHA.117.025827. Review.</citation>
    <PMID>28947480</PMID>
  </reference>
  <reference>
    <citation>Zellerhoff S, Ullerich H, Lenze F, Meister T, Wasmer K, Mönnig G, Köbe J, Milberg P, Bittner A, Domschke W, Breithardt G, Eckardt L. Damage to the esophagus after atrial fibrillation ablation: Just the tip of the iceberg? High prevalence of mediastinal changes diagnosed by endosonography. Circ Arrhythm Electrophysiol. 2010 Apr;3(2):155-9. doi: 10.1161/CIRCEP.109.915918. Epub 2010 Mar 1.</citation>
    <PMID>20194799</PMID>
  </reference>
  <reference>
    <citation>Kadado AJ, Akar JG, Hummel JP. Luminal esophageal temperature monitoring to reduce esophageal thermal injury during catheter ablation for atrial fibrillation: A review. Trends Cardiovasc Med. 2019 Jul;29(5):264-271. doi: 10.1016/j.tcm.2018.09.010. Epub 2018 Sep 19. Review.</citation>
    <PMID>30282588</PMID>
  </reference>
  <reference>
    <citation>Kaneshiro T, Matsumoto Y, Nodera M, Kamioka M, Kamiyama Y, Yoshihisa A, Ohkawara H, Suzuki H, Takeishi Y. Anatomical predisposing factors of transmural thermal injury after pulmonary vein isolation. Europace. 2018 Jul 1;20(7):1122-1128. doi: 10.1093/europace/eux185.</citation>
    <PMID>28605437</PMID>
  </reference>
  <reference>
    <citation>Kottkamp H, Piorkowski C, Tanner H, Kobza R, Dorszewski A, Schirdewahn P, Gerds-Li JH, Hindricks G. Topographic variability of the esophageal left atrial relation influencing ablation lines in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2005 Feb;16(2):146-50.</citation>
    <PMID>15720452</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 4, 2020</study_first_submitted>
  <study_first_submitted_qc>May 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Medico Teknon</investigator_affiliation>
    <investigator_full_name>Antonio Berruezo, MD, PhD</investigator_full_name>
    <investigator_title>Head of the Arrhytmia Unit</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Atypical flutter</keyword>
  <keyword>catheter-based ablation</keyword>
  <keyword>radiofrequency ablation</keyword>
  <keyword>left atrial wall thickness</keyword>
  <keyword>atrio-esophageal relationship</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

